Big pharma News
|
The opioid epidemic in the U.S. is getting worse by the day and to many of us, Big Pharma has Congress by the short hairs in order to protect their $9 billion a year in profits. Well, apparently, this is exactly what's happening.
|
London -
New figures, relating to the U.K., reveal some of the payments made by pharmaceutical companies to the medical profession. The key word is “some”, since the declarations remain voluntary.
|
|
In the latest pharmaceutical news round-up there is a new push to eliminate polio, a new treatment for COPD, and unfortunate news that a patient has died after taking an anti-psychotic medication.
|
|
Pharmaceutical company AstraZeneca is to embark on an ambitious project that will see the drugs giant sequence 2 million genomes in the quest for new candidate drug products.
|
|
Pharmaceutical company Novartis experienced mixed results during the first quarter of 2016. Sales showed a decline, however the company is preparing to launch a significant new anti-seizure medication.
|
As we do at regular intervals, Digital Journal dips into the latest news stories relating to the colorful world of pharmaceuticals. This week there are new drugs announced and old scores to settle.
|
|
London -
Pharmaceutical company GlaxoSmithKline (GSK), together with several generics companies, has been fined for being anti-competitive and keeping the price of an anti-depressant drug artificially high.
|
Medical devices are becoming the latest equipment to utilize the Internet to collect data and to send alerts. Here ‘smart inhalers’ are leading the way, with the first commercial units expected within a year. We take a look at the latest developments.
|
|
Human society needs a new generation of antimicrobials to overcome the problem of multi-drug resistance. A key question stemming from this is who should pick up the bill?
|
|
Concerns have been expressed over the past few years about the independence of clinical trials, due to the funding of some trials by corporations with vested interests. New data suggests this is now the norm rather than the exception.
|
|
Two big deals in the world of pharmaceuticals have been announced this week. Pfizer has announced it is to merge with Allergan; and Shire is making a bid for Baxalta.
|
|
London -
The Good Pharma Scorecard is a system that ranks drugs based on their transparency and ethical practices. A review of some big pharma companies reveals several inconsistencies.
|
|
Washington -
Democratic presidential candidate Bernie Sanders campaign received a maximum individual donation of $2,700 from Mark Shkreli, Turing Pharmaceutical CEO, who's been branded as the Big Pharma "poster boy" by a Sander's staffer.
|
|
It has been a busy week in the pharmaceutical sector, with big players Lubrizol, GSK and Purdue announcing acquisitions or partnerships with other pharmaceutical companies.
|
|
London -
Medical doctors and other health officials could be instructed to declare all financial links to pharmaceutical companies. New plans are being drawn up in the U.K. to make this mandatory.
|
|
The latest figures for the amount of money spent by the pharmaceutical industry on the medical profession for the U.K. has been revealed — £41 million ($60 million). This is dwarfed by the amount spent in the U.S.
|
|
It has been a mixed week for the pharmaceutical sector in terms of drug development, with success for Novartis and disappointing news for Boehringer and Vitae Pharma. Digital Journal reports on the latest news.
|
Pharma company Alexion, which specializes in rare disease research, has purchased a smaller drug developer, Synageva biopharmaceuticals, for over $8 billion.
|
|
The Federal Court of Australia has rejected an appeal of a ruling that allows companies to patent isolated human genes. This reignites the debate: who owns your genes - you or the company that extracts them?
|
|
Several U.K. research groups have agreed to publicly disclose more information about their animal subjects and the number of animal experiments undertaken each year.
|
Major pharmaceutical companies are hindering the development of new antibiotics, according to the Royal Pharmaceutical Society (U.K.).
|
|
Japan's biggest pharmaceutical company has been hit with a $6 billion penalty for concealing cancer risks associated with its Actos diabetes drug while Eli Lilly and Co, Takeda's co-defendant in the case, was ordered to pay $3 billion in punitive damages.
|
|
There's a new drug regimen being touted as a potential cure for a dangerous liver virus that causes hepatitis C. But it costs $84,000 -- or $1,000 a pill.
|
The size of a company and its economic resources is not tied to getting a drug to market, according to a new report. The success of small companies sometimes challenges the might of "big pharma."
|
|
In a move described as 'transparent', the major drugs companies have agreed to share data from clinical trials with researchers, patients, and the public.
|
|
A campaign has been launched to provide training for healthcare providers in sub-Saharan Africa. This is part of UN sustainable development initiative.
|
|
Spending by major pharmaceutical companies to U.S. doctors exceeded $1 billion in 2012, according to some newly released figures.
|
|
A group of medics have warned that the inflated prices charged by pharmaceutical firms for drugs to treat cancer are threatening patients' lives.
|
The pharmaceutical company AstraZeneca has announced two rounds of significant job cuts in an attempt to boots its profitability.
|
|
The pharma company Teva has been fined by U.S. authorities for pumping a fluorescent green discharge into a river at its plant in northeast Missouri.
|
apis-319826 apis-306286 apis-304915 apis-304125 apis-297751 apis-296677 apis-293054 apis-291292 apis-289473 apis-286745 apis-283107 apis-279599 apis-278275 apis-277385 apis-251640 apis-240352 apis-236110 apis-230291 apis-211091 apis-206709 apis-206508 apis-204941 apis-200640
Big pharma Image
GlaxoSmithKline headquaters in Brentford, London, England Maxwell Hamilton
A new report suggests the pharmaceutical industry played a major role in the 2009 swine flu pandemic declaration.
Well? If you are, it's no thanks to these bastards.
J. Michael Pearson, CEO of the publicly traded Montreal-based Valeant Pharmaceuticals International. Illustration by Digital Journal / Photo inset Valeant
|
|
